Robert Driscoll's Stock Ratings

Wedbush Analyst

Robert Driscoll is an analyst at Wedbush. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/01/2024

Overall Average Return

29.7%

Smart Score

72.9%

Overall Average Return Percentile

87th

Number of Ratings

117
Buy NowGet Alert
05/23/2024TNGXBuy Now
Tango Therapeutics
$6.9258.96%$18 → $11MaintainsOutperformGet Alert
05/22/2024GLUEBuy Now
Monte Rosa Therapeutics
$4.12166.99% → $11ReiteratesOutperform → OutperformGet Alert
05/16/2024CGEMBuy Now
Cullinan Therapeutics
$23.5053.19% → $36ReiteratesOutperform → OutperformGet Alert
05/16/2024ALPNBuy Now
Alpine Immune Sciences
$64.990.02% → $65ReiteratesNeutral → NeutralGet Alert
05/10/2024TYRABuy Now
Tyra Biosciences
$16.2272.63% → $28ReiteratesOutperform → OutperformGet Alert
05/09/2024CTMXBuy Now
CytomX Therapeutics
$1.74359.77%$3 → $8UpgradeNeutral → OutperformGet Alert
05/09/2024RCUSBuy Now
Arcus Biosciences
$15.00100% → $30ReiteratesOutperform → OutperformGet Alert
05/09/2024IGMSBuy Now
IGM Biosciences
$8.33140.1% → $20ReiteratesOutperform → OutperformGet Alert
05/09/2024RVMDBuy Now
Revolution Medicines
$38.3320.01%$42 → $46MaintainsOutperformGet Alert
05/08/2024JANXBuy Now
Janux Therapeutics
$53.5038.32%$53 → $74MaintainsOutperformGet Alert
05/08/2024ARVNBuy Now
Arvinas
$33.1472% → $52ReiteratesOutperform → OutperformGet Alert
05/08/2024IDYABuy Now
IDEAYA Biosciences
$36.5542.27% → $52ReiteratesOutperform → OutperformGet Alert
05/03/2024KURABuy Now
Kura Oncology
$20.6179.52% → $37ReiteratesOutperform → OutperformGet Alert
05/03/2024ELEVBuy Now
Elevation Oncology
$4.0299% → $8ReiteratesOutperform → OutperformGet Alert
04/23/2024ACETBuy Now
Adicet Bio
$1.60212.5% → $5ReiteratesOutperform → OutperformGet Alert
04/11/2024ALPNBuy Now
Alpine Immune Sciences
$64.99——DowngradeOutperform → NeutralGet Alert
04/10/2024GERNBuy Now
Geron
$3.5569.01% → $6ReiteratesOutperform → OutperformGet Alert
04/10/2024FHTXBuy Now
Foghorn Therapeutics
$5.83122.98% → $13ReiteratesOutperform → OutperformGet Alert
04/08/2024BDTXBuy Now
Black Diamond Therapeutic
$4.76236.13%$10 → $16MaintainsOutperformGet Alert
03/27/2024APREBuy Now
Aprea Therapeutics
$4.65136.56%$9 → $11MaintainsOutperformGet Alert
03/22/2024CMPXBuy Now
Compass Therapeutics
$1.41467.38% → $8ReiteratesOutperform → OutperformGet Alert
03/21/2024TYRABuy Now
Tyra Biosciences
$16.2272.63% → $28ReiteratesOutperform → OutperformGet Alert
03/20/2024ACETBuy Now
Adicet Bio
$1.60212.5% → $5ReiteratesOutperform → OutperformGet Alert
03/19/2024ALPNBuy Now
Alpine Immune Sciences
$64.99-27.68% → $47ReiteratesOutperform → OutperformGet Alert
03/15/2024GERNBuy Now
Geron
$3.5569.01% → $6ReiteratesOutperform → OutperformGet Alert
03/13/2024BDTXBuy Now
Black Diamond Therapeutic
$4.76110.08% → $10ReiteratesOutperform → OutperformGet Alert
03/12/2024CTMXBuy Now
CytomX Therapeutics
$1.7472.41% → $3ReiteratesNeutral → NeutralGet Alert
03/08/2024IGMSBuy Now
IGM Biosciences
$8.33140.1% → $20ReiteratesOutperform → OutperformGet Alert
03/08/2024FHTXBuy Now
Foghorn Therapeutics
$5.83122.98% → $13ReiteratesOutperform → OutperformGet Alert
03/07/2024ELEVBuy Now
Elevation Oncology
$4.0299%$5 → $8MaintainsOutperformGet Alert